PubMed · 15008806
Does nicotine affect D2 receptor upregulation? A case-control study.
Abstract
OBJECTIVE: Nicotine has a powerful preventive effect on neuroleptic-induced dopamine D2 receptor upregulation in the rat. The aim of this human positron emission tomography (PET) study was to compare upregulation in a smoker and a non-smoker, both of whom had received haloperidol for the same duration of time. METHOD: Two subjects who had been treated for 16 years with a constant dose of haloperidol were scanned after temporary haloperidol withdrawal, using [11C]-raclopride. RESULTS: The non-smoker, who had received a dose of 10 mg/day, showed a D2 upregulation of 98% and developed severe and persistent symptoms of tardive dyskinesia (TD) upon withdrawal. The chronic smoker, who had been treated with 40 mg/day, displayed a D2 upregulation of 71% and did not develop TD. CONCLUSION: These human observations agree with animal data which showed that nicotine can decrease neuroleptic-induced D2 receptor upregulation. This property of nicotine may play a protective role in movement disorders whose pathophysiology involves D2 receptor hypersensitivity.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
S Silvestri, J C Negrete, M V Seeman, C M Shammi, P Seeman. 2004. Does nicotine affect D2 receptor upregulation? A case-control study.. https://doi.org/10.1111/j.1600-0447.2004.00293.x. https://pubmed.health/record/pubmed%3A15008806/does-nicotine-affect-d2-receptor-upregulation-a-case-control-study
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.